S&P 500 Healthcare Sector SEC Filings — February 11, 2026

12-02-2026

Baxter International Inc. filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007474), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). Specific details including the officer's name, position, reason for change, timing, financial metrics, or quantitative data are NOT_DISCLOSED. No positive or negative performance metrics, period-over-period comparisons, or scheduled events are mentioned.

• ·Filing size: 1 MB
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

12-02-2026

Canadian Pacific Kansas City Ltd filed a Form 8-K on February 12, 2026 (AccNo: 0001193125-26-048127, Size: 193 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, transaction values, financial metrics, or exhibit contents are disclosed. This appears to be a multi-item informational filing with no quantified positive or negative impacts mentioned.

• ·Accession Number: 0001193125-26-048127

11-02-2026

Newmarket Corp filed an 8-K on February 11, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing details. This is an informational earnings-related disclosure with no quantitative metrics available.

11-02-2026

Peapack Gladstone Financial Corp filed an 8-K on February 11, 2026, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

11-02-2026

Biogen Inc. filed a Form 8-K on 2026-02-11 disclosing an unspecified officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

11-02-2026

STRATA Skin Sciences, Inc. filed a Form 8-K on 2026-02-11 disclosing under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 8.01 reports Other Events. No quantitative financial metrics, transaction values, or period-over-period comparisons are disclosed.

11-02-2026

GCI Liberty, Inc. filed an 8-K on February 11, 2026, disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results, but no specific revenue, earnings, margins, comparisons, or guidance metrics are disclosed in the provided information. No positive or negative performance indicators, period-over-period changes, or quantitative impacts are mentioned.

11-02-2026

Community Financial System, Inc. filed an 8-K on February 11, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative impacts are disclosed.

11-02-2026

USANA Health Sciences Inc filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, timing, or quantitative data are disclosed.

11-02-2026

Cipher Mining Inc. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with no specific details on position, individual, or reasons provided. The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No quantitative metrics, performance comparisons, or further context on the change's implications are disclosed.

11-02-2026

PennyMac Financial Services, Inc. filed an 8-K on February 11, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This appears to be a multi-item filing involving voluntary disclosure of material information under Regulation FD, with attached exhibits. No specific financial metrics, transactions, events, or quantitative data are detailed in the provided filing summary.

11-02-2026

Glacier Bancorp, Inc. filed an 8-K on February 11, 2026 (AccNo: 0000868671-26-000013, Size: 5 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing indicates a voluntary disclosure of potentially material non-public information with attached exhibits, such as press releases or presentations. No specific financial metrics, transactions, guidance, or events are detailed in the provided filing summary.

11-02-2026

Jefferies Financial Group Inc. filed an 8-K on February 11, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits (file size 255 KB, AccNo: 0001140361-26-004802). No specific details, financial metrics, transactions, positive or negative changes, or quantitative data are disclosed in the filing summary. This appears to be a voluntary disclosure of material information with attached exhibits.

11-02-2026

Social Commerce Partners Corp filed an 8-K on February 11, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, comparisons, or directional impacts are mentioned.

11-02-2026

Jackson Financial Inc. filed an 8-K on February 11, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Specific details of the other events or contents of the exhibits are NOT_DISCLOSED. No financial metrics, transactions, or directional impacts are explicitly stated.

11-02-2026

CID Holdco, Inc. filed a Form 8-K on February 11, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, and under Item 3.01 notice of delisting or failure to satisfy a continued listing rule or standard, with Item 9.01 providing financial statements and exhibits. No quantitative details such as transaction values, financial impacts, dollar amounts, or specific terms are disclosed. This multi-item filing suggests potential financial distress without offsetting positive metrics disclosed.

11-02-2026

FB Financial Corp filed an 8-K on February 11, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item voluntary filing with a file size of 9 MB, likely attaching disclosure materials such as a press release or presentation. No specific financial metrics, transactions, events, or quantitative data are disclosed in the provided filing summary.

11-02-2026

CNO Financial Group, Inc. filed an 8-K on 2026-02-11 disclosing matters under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. The filing also includes Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on affected positions, names, appointment or resignation status, reasons, or any quantitative metrics are disclosed.

• ·Sector: sector not specified
• ·Filing Accession Number: 0001224608-26-000011
• ·Filing Size: 484 KB

11-02-2026

First American Financial Corp filed an 8-K on February 11, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or other quantitative financial metrics were mentioned in the filing details provided. This is a standard voluntary earnings release filing with no directional performance indicators available.

11-02-2026

Cisco Systems, Inc. filed a Form 8-K on February 11, 2026, under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or operational details are mentioned.

11-02-2026

CoreCivic, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001193125-26-046527), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.

11-02-2026

Neurocrine Biosciences Inc filed an 8-K on February 11, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

12-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001062993-26-000822, Size: 587 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the core event, transaction values, financial metrics, or performance comparisons disclosed in the provided information. No quantitative data, period-over-period changes, positive or negative metrics, or strategic implications are available.

12-02-2026

News Corp filed a Form 8-K on February 12, 2026 (AccNo: 0001564708-26-000033, size: 399 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the provided filing information. This appears to be a multi-item informational filing with no quantitative metrics, positive or negative performance indicators, or directional implications provided.

12-02-2026

Bally's Corp filed an 8-K on February 12, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events or content of the exhibits are disclosed in the filing summary. No financial metrics, transactions, or directional impacts are mentioned.

12-02-2026

Zoetis Inc. filed a Form 8-K on 2026-02-12 (AccNo: 0001555280-26-000008) under Item 2.02 reporting results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure without detailed metrics available for analysis.

12-02-2026

Kelly Services Inc filed an 8-K on 2026-02-12 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed financial data available.

12-02-2026

Axos Financial, Inc. filed a Form 8-K on 2026-02-12 under Item 1.01 disclosing entry into a Material Definitive Agreement. Item 9.01 provides Financial Statements and Exhibits. No further details on the agreement, transaction size, financial impacts, or other metrics are disclosed.

12-02-2026

Ryan Specialty Holdings, Inc. filed a Form 8-K on February 12, 2026, reporting under Item 5.08 regarding Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 and Item 8.01 Other Events. No financial metrics, transaction details, quantitative data, or specific events were disclosed in the filing summary provided. This is an informational disclosure with no apparent positive or negative financial impacts mentioned.

12-02-2026

12-02-2026

Tectonic Financial, Inc. filed an 8-K on February 12, 2026, reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. The filing also includes Regulation FD disclosure under Item 7.01 and lists financial statements and exhibits under Item 9.01. No quantitative details, dollar values, strategic impacts, or performance metrics are disclosed.

12-02-2026

Sprout Social, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001517375-26-000003), disclosing results of operations and financial condition under Item 2.02 alongside an officer change or related event under Item 5.02. Item 5.02 covers potential departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements, but specific details including names, positions, reasons, and timing are NOT_DISCLOSED. No financial metrics, quantitative changes, or performance comparisons are provided in the available information.

12-02-2026

CIM Real Estate Finance Trust, Inc. filed an 8-K on February 12, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No transaction details, dollar values, financial metrics, or impacts are disclosed.

12-02-2026

Citigroup Inc. filed an 8-K on February 12, 2026, under Item 5.03 reporting amendments to its Articles of Incorporation or Bylaws, or a change in fiscal year. Item 9.01 discloses financial statements and exhibits. No details on the nature of amendments, financial impacts, or quantitative metrics were provided.

12-02-2026

Sixth Street Specialty Lending, Inc. filed an 8-K on 2026-02-12 disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing details. This is a multi-item voluntary earnings-related disclosure.

12-02-2026

Vertex Pharmaceuticals Inc. / MA filed a Form 8-K on February 12, 2026 (AccNo: 0000875320-26-000034), reporting results of operations and financial condition under Item 2.02 and financial statements and exhibits under Item 9.01. This is a multi-item filing typical for earnings releases, but no specific revenue, earnings, guidance, balance sheet details, or other quantitative metrics were explicitly stated. No positive, negative, or flat performance indicators were disclosed.

12-02-2026

Thermo Fisher Scientific Inc. filed an 8-K on February 12, 2026 (AccNo: 0001140361-26-005014), reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed in the provided filing summary.

12-02-2026

Catheter Precision, Inc. filed a multi-item 8-K on February 12, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD disclosure (Item 7.01). While the material agreement may signal strategic progress, the unregistered equity sales raise potential dilution concerns and the governance changes introduce uncertainty without specified details. No quantitative transaction values, share counts, financial impacts, or period-over-period comparisons are disclosed.

12-02-2026

FrontView REIT, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048763), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or quantitative metrics are disclosed in the provided information. No positive or negative performance metrics, period-over-period comparisons, or guidance changes are mentioned.

12-02-2026

Pacific Biosciences of California, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001299130-26-000017), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing information.

12-02-2026

Ameriprise Financial Inc filed an 8-K on February 12, 2026 (AccNo: 0001104659-26-014312), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or financial terms are provided. No quantitative metrics, performance comparisons, or other financial data are mentioned.

12-02-2026

Brighthouse Financial, Inc. filed a Form 8-K on February 12, 2026, reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely related to annual shareholder meeting outcomes and additional material disclosures. No specific vote results, quantitative financial metrics, positive or negative changes, or other details are disclosed in the provided filing summary.

12-02-2026

MVB Financial Corp filed an 8-K on February 12, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative details are mentioned in the filing description. This is a standard earnings-related disclosure for a financial institution.

12-02-2026

Cineverse Corp. filed a Form 8-K on 2026-02-12 reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 2.02 Results of Operations and Financial Condition, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, financial metrics, or period-over-period comparisons disclosed in the provided information. No positive or negative metrics are available.

12-02-2026

Bain Capital Specialty Finance, Inc. filed an 8-K on February 12, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, quantitative data, period-over-period comparisons, or guidance were mentioned in the filing details provided. This appears to be a standard earnings-related disclosure without detailed performance indicators.

12-02-2026

FINANCIAL INSTITUTIONS INC filed an 8-K on February 12, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing represents a voluntary disclosure of material nonpublic information with attached exhibits, but no specific details, financial metrics, transactions, or performance data are provided in the filing summary. No positive or negative metrics are disclosed.

12-02-2026

Corebridge Financial, Inc. filed a Form 8-K on 2026-02-12 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 references financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative impacts, or comparisons are disclosed.